- Published on
Diagnostic Tests – CK-MB
What Is CK-MB?
CK-MB (Creatine Kinase–Myocardial Band) is a cardiac enzyme released into the bloodstream when myocardial cells are damaged. It serves as a marker of acute myocardial injury, most commonly used in the evaluation of suspected myocardial infarction (MI). CK-MB levels begin to rise approximately 4–6 hours after the onset of chest pain, reach their peak at around 12–24 hours, and then decline relatively quickly because CK-MB has a shorter half-life than troponin.
Because of this rapid return to baseline, CK-MB is particularly useful for detecting reinfarction, where a second rise in enzyme levels may occur after an earlier MI.
When Is CK-MB the Correct Answer?
CK-MB should be selected when evaluating a patient with possible ischemic chest pain, especially if risk factors for coronary disease are present. Importantly, CK-MB can be elevated even when the EKG is nondiagnostic or lacks ST-segment elevation.
It is also the correct choice when chest pain recurs shortly after a recent myocardial infarction—usually within the previous few days. Because CK-MB falls faster than troponin, a new rise in CK-MB can reliably indicate re-infarction, making it uniquely valuable in this scenario.
0 Comments
